Giulia Fornaro

Government, Health and Not for Profit

Latest publications

ARMENI P., BORSOI L., FORNARO G., JOMMI C., COLOMBO N., COSTA F. Cost-Effectiveness and Net Monetary Benefit of olaparib Maintenance Therapy Versus No Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-Mutated Ovarian Cancer in the Italian National Health Service Clinical Therapeutics, 2020, vol.42, no. 7, pp.1192-1209
ARMENI P., BORSOI L., FORNARO G., JOMMI C., Grossi Francesco, COSTA F. Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non–small Cell Lung Cancer in the Italian National Health Service Clinical Therapeutics, 2020, vol.42, no. 5, pp.830-847
TORBICA A., FORNARO G., TARRICONE R., DRUMMOND M. Do Social Values and Institutional Context Shape the Use of Economic Evaluation in Reimbursement Decisions? An Empirical Analysis Value In Health, 2020, vol.23, no. 1, pp.17-24
CIANI O., FEDERICI C. B., FORNARO G., ROGNONI C. Value-based healthcare: Il nuovo approccio di AIFA alla determinazione multidimensionale del valore Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, 2020, vol.7, no. 1, pp.9-13